FDA: Antidepressant meets efficacy tests, after all

The Food and Drug Administration’s Office of New Drugs has ruled in favor of the efficacy of gepirone extended release for treating major depressive disorder. The decision overturns a decision by the...

Source: Clinical Psychiatry News - March 22, 2016 Category: Psychiatry Source Type: research